Posted by Michael Wonder on 02 Jun 2026
Loargys (pegzilarginase for injection) approved in Canada for the treatment of arginase 1 deficiency
1 June 2026 - Immedica announces that Health Canada has granted a Notice of Compliance on 29 May 2026 for Loargys (pegzilarginase for injection) for the treatment of hyperargininaemia in adults and paediatric patients aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction.
Loargys is approved in the EU, UK, US, Canada and Oman for the treatment of arginase 1 deficiency, also known as hyperargininaemia, in adults, adolescents, and children 2 years and older.
